The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura

Lignende værker

• Balancing Therapy with Thrombopoietin Receptor Agonists and Splenectomy in Refractory Immune Thrombocytopenic Purpura: A Case of Postsplenectomy Thrombocytosis Requiring Plateletpheresis
  af: Zimmerman, Jacquelyn, et al.
  Udgivet: (2016)
• A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists
  af: Khan, Meaghan, et al.
  Udgivet: (2010)
• Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy
  af: VA Shuvaev, et al.
  Udgivet: (2017-10-01)
• Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists
  af: Meyer, Oliver, et al.
  Udgivet: (2012)
• Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy
  af: VA Shuvaev, et al.
  Udgivet: (2017-10-01)